MSD has reported outcomes from a Phase III trial of Keytruda (pembrolizumab) for treating head and neck squamous cell ...

US-based pharmaceutical company MSD has reported ... Last month, MSD and BioCity Biopharmaceuticals partnered to assess Keytruda in combination with BC3195 in a global Phase I/II study for ...

At the Standalone during the January to March 2025 quarter, the Sudarshan Pharma Industries net profit at ₹9.95 crore also saw a sharp rise The net profit for the quarter reported buy the ...

Artificial intelligence (AI) has the potential to reshape the pharmaceutical industry, potentially cutting drug development time by up to 70% and reducing the number of clinical trial phases ...

2025 (Spring) Pharmaceutical Machinery Exposition Concludes Successfully This year's exposition attracted a total of 1,686 exhibitors from 24 countries and regions, showcasing over 10,000 products ...

On April 1, the Trump administration launched an investigation of whether imports of pharmaceuticals pose a national security risk. Given the relatively short period for public comments ...

Muhammad Pate, announced on Sunday that the Presidential Initiative for Unlocking the Healthcare Value Chain aims to increase local manufacturing of pharmaceutical products in Nigeria to at least ...

The chief executive of AstraZeneca (AZN.L), opens new tab said on Tuesday that the drugmaker will maintain its 2025 sales guidance even if the U.S. levies tariffs on pharma products made in the ...

LONDON (Reuters) -A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on, a report ...

Pharmaceutical company Eli Lilly announced promising clinical trial results this week for a daily pill to treat obesity and diabetes. Besides the good news of minimal side effects and impressive ...